print   Print full article


The goals with testing are to diagnose myasthenia gravis (MG), distinguish it from other conditions with similar symptoms, and to guide treatment. Some tests may be performed to monitor a person's health status over time.

Laboratory tests
Laboratory testing may include the measurement of one or more autoantibodies:

  • Acetylcholine receptor Ab (ACHR)—found in up to 90% of those with generalised MG and about 50% of those with ocular MG; this is the primary blood test for MG. There are three types of ACHR antibodies: binding (most frequently tested), blocking, and modulating.
  • Anti-MuSK (muscle-specific kinase) antibodies—found in up to 70% of those who are negative for AchR antibodies and have generalized MG.
  • Anti-Striated muscle antibody test—found in about 80% of those with MG who have an enlarged thymus gland and indicate a significantly increased likelihood of the person having a thymoma.
Other testing that may sometimes be ordered: Non-laboratory tests
  • Tensilon test (acetylcholinesterase test using edrophonium)—a person is given a drug intravenously to see if muscle strength improves for a few minutes (for more on this, see MedlinePlus Medical Encyclopedia: Tensilon test).
  • Repetitive nerve stimulation and/or single-fibre electromyography—to evaluate neuromuscular response in a specific area.
  • A chest CT scan (computed tomography)—to detect an enlarged thymus gland or thymoma.
  • A brain and eye orbit MRI (magnetic resonance imaging)—this is not routine but can help rule out other causes of eye-related symptoms.

Last Review Date: August 1, 2018